Cortical Plasticity Across Phase of Illness in Schizophrenia
Cortical Plasticity Across Phase of Illness in Schizophrenia
批准号:
9180454
负责人:
Amanda McCleery
金额:
$16.86万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2021-06-30
关键词:
AccountingAgeAnimalsAuditoryBehaviorBehavioralBiological MarkersBiometryBrainBrain InjuriesChemosensitizationChronicChronic PhaseChronic SchizophreniaClinical PsychologyClinical ResearchCognitionCognitiveCollectionCommunitiesComplexControl GroupsDataDevelopmentDevelopmental CourseDiagnosisDimensionsDiseaseEarly InterventionEconomic BurdenEducational InterventionElectroencephalographyElectrophysiology (science)EventEvent-Related PotentialsFrequenciesFunctional disorderGoalsHumanImpaired cognitionIndividualInterventionKnowledgeLearningLong-Term PotentiationLongevityMeasuresMemoryMental disordersMentorsMethodsModelingNational Institute of Mental HealthNeurobiologyNeurosciencesOccupationalParticipantPerformancePhasePlant RootsPopulationPopulation HeterogeneityProcessPsychopathologyResearchResearch InfrastructureResearch PersonnelSchizophreniaSensorySocietiesStagingStrategic PlanningSynapsesTestingTimeTrainingVisualVisual evoked cortical potentialWorkbaseclinical biomarkerscognitive processcognitive trainingcomputerizedcostcritical perioddaily functioningdevelopmental psychologydisabilityexperiencefunctional disabilityfunctional outcomesimprovedin vivoindependent component analysisindexinginformation processingneural circuitneural correlateprogramsrelating to nervous systemresponsesensory cortexsevere mental illnessskillssocialsynaptic depression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Individuals with schizophrenia suffer from marked cognitive impairment, which is highly predictive of social,
occupational, and community functioning. As a result, cognitive impairment is a prime target for intervention.
Abnormalities in cortical plasticity are hypothesized to underlie cognitive impairment. However, because it was
not possible to evaluate human cortical plasticity in vivo until very recently, the extent to which cortical plasticity
is impacted in schizophrenia is unclear. Furthermore, it is unknown whether cortical plasticity changes over
phase of illness. Animal studies indicate that cortical plasticity declines with age. It is possible that in
schizophrenia, normative maturational declines in cortical plasticity interact synergistically with disease
pathophysiology over the developmental course of the illness. Thus, cortical plasticity may be less
compromised in the early phase of illness. Finally, little is known about the real-world consequences of
abnormal cortical plasticity for individuals with schizophrenia. This K23 project is consistent with strategies
outlined in the NIMH Strategic Plan, particularly Strategy 1.1., to describe the neural circuits associated with
complex behaviors, Strategy 2.1, to characterize the developmental trajectories of brain maturation and
dimensions of behavior to understand the roots of mental illnesses across diverse populations, and Strategy
2.2, to identify clinically useful biomarkers that predict change across the trajectory of illness. Specifically, the
proposal involves a plan for the applicant to work closely with a diverse team of distinguished researchers with
expertise in neuroscience, clinical and developmental psychology, and biostatistics to investigate biomarkers of
cortical plasticity in schizophrenia within a neurodevelopmental framework. Using newly-developed EEG
paradigms that permit non-invasive assessment of plasticity in the human sensory cortex, we will study
individuals with recent-onset schizophrenia, chronic schizophrenia, and matched non-psychiatric comparison
participants to investigate: 1) whether cortical plasticity is abnormal in schizophrenia, 2) whether cortical
plasticity changes over phase of illness, and 3) potential correlates of cortical plasticity in schizophrenia,
including performance-based tasks of perceptual processing and higher-order cognition, and daily functioning.
The findings will inform the field about the developmental course of the neural underpinnings of impaired
cognition in schizophrenia, and will inform plasticity-based interventions to improve cognition in this population.
Mentored training in advanced EEG analytic methods and developmental psychopathology will permit the
applicant to develop an independent, interdisciplinary program of clinical research that combines
electrophysiology and behavioral methods to investigate cognition and functioning in severe psychopathology
across the lifespan.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cortical Plasticity Across Phase of Illness in Schizophrenia
-
批准号:10435304
-
项目类别:
-
资助金额:$6.99万
-
财政年份:2016
-
负责人:Amanda McCleery
-
依托单位:
Cortical Plasticity Across Phase of Illness in Schizophrenia
-
批准号:9306954
-
项目类别:
-
资助金额:$16.86万
-
财政年份:2016
-
负责人:Amanda McCleery
-
依托单位:
Cortical Plasticity Across Phase of Illness in Schizophrenia
-
批准号:10246696
-
项目类别:
-
资助金额:$16.59万
-
财政年份:2016
-
负责人:Amanda McCleery
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: